Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
LaBranche CC., McGuire AT., Gray MD., Behrens S., Chen X., Zhou T., Sattentau QJ., Peacock J., Eaton A., Greene K., Gao H., Tang H., Perez LG., Saunders KO., Kwong PD., Mascola JR., Haynes BF., Stamatatos L., Montefiori DC.
[This corrects the article DOI: 10.1371/journal.ppat.1007431.].